Targeting Signal 1 Through CD45RB Synergizes with CD40 Ligand Blockade and Promotes Long Term Engraftment and Tolerance in Stringent Transplant Models
Open Access
- 1 January 2001
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 166 (1), 322-329
- https://doi.org/10.4049/jimmunol.166.1.322
Abstract
The induction and maintenance of allograft tolerance is a daunting challenge. Although combined blockade of CD28 and CD40 ligand (CD40L)-costimulatory pathways prevents allograft rejection in some murine models, this strategy is unable to sustain engraftment in the most immunogenic allograft and strain combinations. By targeting T cell activation signals 1 and 2 with the novel combination of anti-CD45RB and anti-CD40L, we now demonstrate potent enhancement of engraftment in C57BL/6 recipients that are relatively resistant to costimulatory blockade. This combination significantly augments the induction of tolerance to islet allografts and dramatically prolongs primary skin allograft survival. Compared with either agent alone, anti-CD45RB plus anti-CD40L inhibits periislet infiltration by CD8 cells, B cells, and monocytes; inhibits Th1 cytokines; and increases Th2 cytokine expression within the graft. These data indicate that interference with activation signals one and two may provide synergy essential for prolonged engraftment in situations where costimulatory blockade is only partially effective.Keywords
This publication has 49 references indexed in Scilit:
- The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivoJCI Insight, 2000
- The Second Domain of the CD45 Protein Tyrosine Phosphatase Is Critical for Interleukin-2 Secretion and Substrate Recruitment of TCR-ζ in VivoPublished by Elsevier BV ,1998
- Differential Regulation of Activation-induced Tyrosine Phosphorylation and Recruitment of SLP-76 to Vav by Distinct Isoforms of the CD45 Protein-tyrosine PhosphatasePublished by Elsevier BV ,1996
- Altered Peptide Ligand–Induced Partial T Cell Activation: Molecular Mechanisms and Role in T Cell BiologyAnnual Review of Immunology, 1996
- Impairment of antigen-specific T-cell priming in mice lacking CD40 ligandNature, 1995
- Transplantation tolerance induced by antigen pretreatment and depleting anti‐CD4 antibody depends on CD4+ T cell regulation during the induction phase of the responseEuropean Journal of Immunology, 1995
- Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA‐1European Journal of Immunology, 1995
- QUANTITATIVE COMPARISON OF RAPAMYCIN AND CYCLOSPORINE EFFECTS ON CYTOKINE GENE EXPRESSION STUDIED BY REVERSE TRANSCRIPTASE-COMPETITIVE POLYMERASE CHAIN REACTION1Transplantation, 1994
- The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndromeCell, 1993
- CELLS MEDIATING ALLOGRAFT REJECTIONTransplantation, 1991